Team Develops Technology That Identifies Defects in Organs Transcription Factors | GenomeWeb

A team of researchers from the Whitehead Institute for Biomedical Research has developed a way to scan an entire human genome and map the location of a mutated transcription factor linked to type 2 diabetes.

If verified by additional research, the study, which marks the first time that scientists have studied transcription factors in individual organs, might also lead to new ways for developing drugs and predicting risk for diabetes and other diseases.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.